Circular RNAs (circRNAs) have been implicated in modulating biological processes in some tumors. However, the contributions and molecular mechanisms of circRNAs to gallbladder cancer (GBC) remain largely unknown. In the present study, our results showed circPVT1 expression was significantly upregulated in GBC tissues and cells. Higher circPVT1 expression was correlated with lymph node metastasis, advanced TNM stage, and poor overall survival (OS) in patients with GBC. Subsequently, knockdown of circPVT1 significantly impeded GBC cell proliferation, migration, invasion, while induced cell apoptosis in vitro. However, upregulated circPVT1 had the opposite effects. In vivo, we also demonstrated that knockdown of circPVT1 inhibited tumor growth. Furthermore, we confirmed that circPVT1 could regulate Myeloid cell leukemia-1 (MCL-1) expression by sponging to miR-339-3p, which affected tumor progression in GBC cells. In summary, our findings indicated that circPVT1 may serve as a promising prognostic marker and therapeutic target for GBC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313687PMC
http://dx.doi.org/10.1038/s41420-021-00577-yDOI Listing

Publication Analysis

Top Keywords

circpvt1
8
gallbladder cancer
8
sponging mir-339-3p
8
mcl-1 expression
8
circpvt1 expression
8
knockdown circpvt1
8
gbc
6
circpvt1 promotes
4
promotes gallbladder
4
cancer growth
4

Similar Publications

Super-enhancer-associated circPVT1 promotes malignancy of hepatocellular carcinoma via YBX1-mediated RRM2 activation.

Cancer Lett

December 2024

Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China. Electronic address:

Circular RNAs (circRNAs), the essential members of epigenetic reprogramming, are emerging as an appealing layer in hepatocellular carcinoma (HCC). Super-enhancers (SEs) are large clusters of transcriptional enhancers with the tremendous gene activation potential and are extensively investigated in cancer research. The present study explores and uncovers an SE-related circRNA circPVT1, identifying its biological functions and downstream mechanisms in HCC.

View Article and Find Full Text PDF

Studying the non-coding RNA expression and its role in drug resistance mechanisms of gastric cancer.

Pathol Res Pract

January 2025

Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address:

Article Synopsis
  • Gastric cancer is the fifth most common cancer globally, often diagnosed at advanced stages, leading to poor survival rates and challenges in treatment due to drug resistance.
  • Noncoding RNAs (ncRNAs), such as microRNAs and long noncoding RNAs, play crucial roles in the development of drug resistance among gastric cancer patients undergoing chemotherapy.
  • Future treatments targeting ncRNAs may provide new ways to combat drug resistance and improve therapeutic outcomes for gastric cancer.
View Article and Find Full Text PDF

Aging presents a significant challenge to health and social care systems due to the increasing proportion of the elderly population. The identification of reliable biomarkers to assess the progression of aging remains an unresolved question. Circular RNAs (circRNAs) are single-stranded covalently closed RNAs.

View Article and Find Full Text PDF

MEF2A is a transcription factor for circPVT1 and contributes to the malignancy of acute myeloid leukemia.

Int J Oncol

November 2024

Department of Hematology, Hematology Research Center of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.

Article Synopsis
  • Acute myeloid leukemia (AML) has a high risk of relapse and poor survival, with key roles played by circPVT1 and MEF2A in cancer progression that are still being investigated.
  • Research showed that circPVT1 is overexpressed in AML and is regulated by MEF2A, which enhances cell survival and promotes processes linked to cancer spread called epithelial-mesenchymal transition (EMT).
  • CircPVT1 targets microRNA (miR)-455-3p, influencing the regulation of the MCL1 protein to facilitate cancer cell viability and EMT, suggesting that interrupting this pathway could be a potential therapeutic approach for AML.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!